• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

E-Module

An HIV and Rehab Resource

  • Français
  • About
    • 1 – What is this resource about and who is it for?
    • 2 – Why was this resource created?
    • 3 – How can this resource be used?
    • 4 – Can this resource be used for teaching?
    • 5 – How was this resource developed?
    • 6 – Who contributed to developing this adapted resource?
    • 7 – Who funded the development of this resource?
    • 8 – Disclaimer
  • Section 1
    • 1.1 How is “rehabilitation” defined in this resource?
    • 1.2 How can rehabilitation help people living with HIV?
    • 1.3 How can the World Health Organization’s “ICF” help us think about rehabilitation for people living with HIV?
    • 1.4 How can the Episodic Disability Model help us think about rehabilitation for people living with HIV?
    • 1.5 Who provides rehabilitation for people living with HIV?
    • 1.6 Do rehabilitation providers need special skills or training to care for people living with HIV? If so, what?
    • 1.7 What roles do rehabilitation providers have related to HIV?
    • 1.8 When is rehabilitation clinical intervention useful along the HIV care continuum?
  • Section 2
    • 2.1 What do rehabilitation professionals need to know about the stages of HIV infection?
    • 2.2 What do rehabilitation providers need to know about CD4 count and viral load?
    • 2.3 What is the impact of HIV on body systems and why does this matter for rehabilitation providers?
    • 2.4 Who might rehabilitation providers treat?
    • 2.5 What do rehabilitation providers need to know about antiretroviral therapies?
  • Section 3
    • 3.1 What are the rehabilitation interventions that address impairments common among people living with HIV?
    • 3.2 What are the rehabilitation interventions that can address the activity limitations and participation restrictions common among people living with HIV?
    • 3.3 More information on the rehabilitation interventions available for people living with HIV
    • 3.4 – What do rehabilitation providers need to know about their patients’ beliefs and use of traditional healers, spiritual leaders and alternative therapies outside the formal medical system?
  • Section 4
    • 4.1: Intersectionality Theory in the Context of Rehabilitation
    • 4.2: Children and Youth
    • 4.3: HIV and Aging
    • 4.4: Substance Use
    • 4.5: Trauma
    • 4.6: Racialized Populations
    • 4.7: Indigenous Populations
    • 4.8: HIV, Sex and Gender
    • 4.9: HIV and COVID-19
    • 4.10: Is HIV itself a disability?
  • Section 5
    • 5.1 What are outcome measures?
    • 5.2 Why is it important to use outcome measures during rehabilitation with people living with HIV?
    • 5.3 How do rehabilitation providers know if an outcome measure will be useful in practice?
    • 5.4 What are floor and ceiling effects in outcome measurement?
    • 5.5 What is the difference between generic and HIV-specific outcome measures?
    • 5.6 How should you decide which outcome measures to use?
    • 5.7 How do you access a copy of an outcome measure?
    • 5.8 What are rehabilitation-related outcome measures that can be useful for people living with HIV?
  • Case Studies
    • Case #1 – Acute Care, Cardiorespiratory and Neurological
    • Case #2 – Musculoskeletal – Knee Pain
    • Case #3 – Aging, Cognition, Community, Stroke
    • Case #4 – Complex Case – Musculoskeletal, Episodic, Cardiorespiratory
    • Case #5 – Diabetes, Neuropathy, Substance Use
    • Case #6 – Transition from Paediatric to Adult Care
    • Supplemental Case Studies without Leading Questions
Hide Search
Show Search

2.2 What do rehabilitation providers need to know about CD4 count and viral load?

CD4 count and viral load are two of the surrogate markers (clues) used to understand disease progression in HIV. These measures will help a rehabilitation provider understand a patient’s immune system at a single point in time as well as changes in immune status over time. However, it is not necessary to have access to this information to make informed decisions as a rehabilitation provider for the type of treatments and interventions a person living with HIV may benefit from.

2.2.1 CD4 count

Cells in a person’s body with CD4 receptors on their surface are the primary targets destroyed by HIV.

CD4 count is the most important surrogate marker for health status and strongest predictor of disease progression.

How to interpret CD4 count:

  • A normal CD4 count level is between 500 to 1500 cells/mm3.
  • CD4 count in a healthy individual varies over time.
  • In a person living with HIV, the CD4 count will become lower as their HIV disease worsens.
  • Opportunistic infections are infections that occur more frequently and are more severe in people with weakened immune systems, including people with HIV.1 Most opportunistic infections occur when a CD4 count is less than 200 cells/mm3.

The CD4 count is influenced by a number of factors (e.g., stress, illness, time at which it was measured) and therefore, the trend in CD4 counts is more important versus one test at a single point in time.

1 HIV.gov. Opportunistic infections.

2.2.2 Viral load

Viral load reflects the amount of virus (HIV) within the body. Viral load is used to predict the rate of progression of HIV disease and to initiate, monitor, and change antiretroviral therapy.

How to interpret viral load levels:

  • The HIV viral load test measures the amount of HIV virus, in each ml or cubic centimeter of blood (e.g., from 50 to 500,000).
  • The higher the viral load, the more viral reproduction (HIV copying itself) is taking place, and the more active (worse) the disease.
  • Viral load tests struggle to measure fewer than 50 HIV viruses in each ml of blood and so the test may say that the viral load is “undetectable.”
    • This does not mean that a person is cured of HIV
    • It also does not mean that the patient should discontinue taking their treatment.
    • An undetectable viral load does mean that a person’s HIV disease is well controlled (but not gone).
    • There is now clear scientific evidence that “Undetectable = Untransmittable” (U=U) and there is a global campaign to spread this message from the HIV scientific community. Research has shown that effective ART prevents sexual transmission of HIV.1

The goal of ART is to reduce viral load to the lowest possible level for the longest possible time.

1 Public Health Agency of Canada. HIV factsheet: U = U for health professionals.

Primary Sidebar

Copyright © 2025 · Realize Canada